77 related articles for article (PubMed ID: 12675238)
1. On the role of dipeptidyl peptidase IV in the digestion of an immunodominant epitope in celiac disease.
Koch S; Anthonsen D; Skovbjerg H; Sjöström H
Adv Exp Med Biol; 2003; 524():181-7. PubMed ID: 12675238
[No Abstract] [Full Text] [Related]
2. Brush border enzyme activities in the small intestine after long-term gliadin feeding in animal models of human coeliac disease.
Kozáková H; Stĕpánková R; Kolínská J; Farré MA; Funda DP; Tucková L; Tlaskalová-Hogenová H
Folia Microbiol (Praha); 1998; 43(5):497-500. PubMed ID: 9821309
[TBL] [Abstract][Full Text] [Related]
3. Breakdown of gliadin peptides by intestinal brush borders from coeliac patients.
Bruce G; Woodley JF; Swan CH
Gut; 1984 Sep; 25(9):919-24. PubMed ID: 6381246
[TBL] [Abstract][Full Text] [Related]
4. Intestinal digestive resistance of immunodominant gliadin peptides.
Hausch F; Shan L; Santiago NA; Gray GM; Khosla C
Am J Physiol Gastrointest Liver Physiol; 2002 Oct; 283(4):G996-G1003. PubMed ID: 12223360
[TBL] [Abstract][Full Text] [Related]
5. [The identification of the immunodominant gliadin epitope].
Sela B
Harefuah; 2003 Jul; 142(7):554-7, 564. PubMed ID: 12908394
[TBL] [Abstract][Full Text] [Related]
6. Tissue transglutaminase and celiac disease.
Esposito C; Caputo I; Auricchio S; Troncone R
Prog Exp Tumor Res; 2005; 38():158-73. PubMed ID: 15746535
[No Abstract] [Full Text] [Related]
7. Deficient activity of mammalian prolyl oligopeptidase on the immunoactive peptide digestion in coeliac disease.
Garcia-Horsman JA; Venäläinen JI; Lohi O; Auriola IS; Korponay-Szabo IR; Kaukinen K; Mäki M; Männistö PT
Scand J Gastroenterol; 2007 May; 42(5):562-71. PubMed ID: 17454876
[TBL] [Abstract][Full Text] [Related]
8. Serum and intestinal dipeptidyl peptidase IV (DPP IV/CD26) activity in children with celiac disease.
Detel D; Persić M; Varljen J
J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):65-70. PubMed ID: 17592366
[TBL] [Abstract][Full Text] [Related]
9. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase.
Molberg O; McAdam S; Lundin KE; Kristiansen C; Arentz-Hansen H; Kett K; Sollid LM
Eur J Immunol; 2001 May; 31(5):1317-23. PubMed ID: 11465088
[TBL] [Abstract][Full Text] [Related]
10. Anti-tissue transglutaminase antibody as the first line screening for celiac disease: good-bye antigliadin tests?
Horvath K; Hill ID
Am J Gastroenterol; 2002 Nov; 97(11):2702-4. PubMed ID: 12425536
[No Abstract] [Full Text] [Related]
11. Extensive in vitro gastrointestinal digestion markedly reduces the immune-toxicity of Triticum monococcum wheat: implication for celiac disease.
Gianfrani C; Camarca A; Mazzarella G; Di Stasio L; Giardullo N; Ferranti P; Picariello G; Rotondi Aufiero V; Picascia S; Troncone R; Pogna N; Auricchio S; Mamone G
Mol Nutr Food Res; 2015 Sep; 59(9):1844-54. PubMed ID: 26016626
[TBL] [Abstract][Full Text] [Related]
12. Diversification of the celiac disease α-gliadin complex in wheat: a 33-mer peptide with six overlapping epitopes, evolved following polyploidization.
Ozuna CV; Iehisa JC; Giménez MJ; Alvarez JB; Sousa C; Barro F
Plant J; 2015 Jun; 82(5):794-805. PubMed ID: 25864460
[TBL] [Abstract][Full Text] [Related]
13. Brush border and cytosol peptidase activities of human small intestine in normal subjects and celiac patients.
Andria G; Cucchiara S; De Vizia B; De Ritis G; Mazzacca G; Auricchio S
Pediatr Res; 1980 Jun; 14(6):812-8. PubMed ID: 6995920
[No Abstract] [Full Text] [Related]
14. Fast and efficient characterization of an anti-gliadin monoclonal antibody epitope related to celiac disease using resin-bound peptides.
Petersen NH; Hansen PR; Houen G
J Immunol Methods; 2011 Feb; 365(1-2):174-82. PubMed ID: 21195715
[TBL] [Abstract][Full Text] [Related]
15. Short-term cultivation of duodenal biopsies in patients with coeliac disease. Effect of gluten challenge and gliadin peptides.
Kocna P; Fric P; Tlaskalová H; Krchnák V; Kasafírek E; Síová M; Czerkinsky C
Adv Exp Med Biol; 1995; 371B():1367-70. PubMed ID: 7502819
[No Abstract] [Full Text] [Related]
16. IgA antibodies of coeliac disease patients recognise a dominant T cell epitope of A-gliadin.
Bateman EA; Ferry BL; Hall A; Misbah SA; Anderson R; Kelleher P
Gut; 2004 Sep; 53(9):1274-8. PubMed ID: 15306584
[TBL] [Abstract][Full Text] [Related]
17. [Peptidase deficiency in celiac disease: the fascination of hypotheses].
Rubino A
Arch Fr Pediatr; 1978 Apr; 35(4):341-4. PubMed ID: 686946
[No Abstract] [Full Text] [Related]
18. [Modern concepts pathogenesis of celiac disease].
Bel'mer SV; Gasilina TV; Usacheva AIu
Eksp Klin Gastroenterol; 2010; (1):86-92. PubMed ID: 20405718
[TBL] [Abstract][Full Text] [Related]
19. Tissue transglutaminase--the key player in celiac disease: a review.
Reif S; Lerner A
Autoimmun Rev; 2004 Jan; 3(1):40-5. PubMed ID: 14871648
[TBL] [Abstract][Full Text] [Related]
20. Transglutaminase-independent binding of gliadin to intestinal brush border membrane and GM1 ganglioside.
Alaedini A; Latov N
J Neuroimmunol; 2006 Aug; 177(1-2):167-72. PubMed ID: 16766047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
